Ambu A/S (OTCMKTS:AMBBY – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the November 30th total of 200 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 0.3 days.
Ambu A/S Stock Performance
AMBBY stock remained flat at $13.02 on Friday. 16 shares of the company traded hands, compared to its average volume of 678. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $3.06 billion and a PE ratio of 108.50. Ambu A/S has a 1 year low of $13.02 and a 1 year high of $22.65. The firm’s 50-day simple moving average is $16.20 and its 200 day simple moving average is $18.48.
Ambu A/S Dividend Announcement
The company also recently declared a dividend, which was paid on Monday, December 23rd. Investors of record on Friday, December 6th were issued a dividend of $0.0557 per share. The ex-dividend date was Friday, December 6th. Ambu A/S’s dividend payout ratio is currently 16.67%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Read More
- Five stocks we like better than Ambu A/S
- How to Read Stock Charts for Beginners
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Short Selling: How to Short a Stock
- Top 3 ETFs to Hedge Against Inflation in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.